ASYMMETRIC DIMETHYLARGININE (ADMA) AND PROGRESSION OF CHRONIC KIDNEY DISEASE: THE MILD TO MODERATE KIDNEY FAILURE (MMKF) STUDY

被引：0
|
作者：
Kielstein, Jan T. [1 ]
Kronenberg, Florian [2 ]
Fliser, Danilo [1 ]
Bode-Boeger, Stefanie M. [3 ]
Ritz, Eberhardt [4 ]
机构：
[1] Hannover Med Sch, Dept Nephrol, Hannover, Germany
[2] Univ Innsbruck, Inst Med Biol & Hum Gen, A-6020 Innsbruck, Austria
[3] Univ Magdeburg, Univ Hosp, Inst Clin Pharmacol, D-39106 Magdeburg, Germany
[4] Heidelberg Univ, Dept Internal Med, Heidelberg, Germany
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A236 / A236
页数：1
相关论文
共 50 条
  • [11] Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease
    van Guldener, Coen
    Nanayakkara, Prabath W. B.
    Stehouwer, Coen D. A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (12) : 1683 - 1687
  • [12] Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study
    Kollerits, B.
    Fliser, D.
    Heid, I. M.
    Ritz, E.
    Kronenberg, F.
    KIDNEY INTERNATIONAL, 2007, 71 (12) : 1279 - 1286
  • [13] Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease
    Lu, Tse-Min
    Chung, Ming-Yi
    Lin, Chih-Ching
    Hsu, Chiao-Po
    Lin, Shing-Jong
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (07): : 1566 - 1572
  • [14] Endothelium, asymmetric dimethylarginine, and atherosclerosis in chronic kidney disease
    Malyszko, Jolanta
    Matuszkiewicz-Rowinska, Joanna
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (03): : 145 - 147
  • [15] Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease - a One-Year Follow-Up Study
    Eiselt, Jaromir
    Rajdl, Daniel
    Racek, Jaroslav
    Vostry, Michal
    Rulcova, Kamila
    Wirth, Jan
    KIDNEY & BLOOD PRESSURE RESEARCH, 2014, 39 (01): : 50 - 57
  • [16] Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases
    Fleck, C
    Schweitzer, F
    Karge, E
    Busch, M
    Stein, G
    CLINICA CHIMICA ACTA, 2003, 336 (1-2) : 1 - 12
  • [17] Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease
    Ueda S.
    Yamagishi S.-I.
    Matsumoto Y.
    Fukami K.
    Okuda S.
    Clinical and Experimental Nephrology, 2007, 11 (2) : 115 - 121
  • [18] Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)
    Ueda, Seiji
    Yamagishi, Sho-Ichi
    Matsumoto, Yuriko
    Kaida, Yusuke
    Fujimi-Hayashida, Ayako
    Koike, Kiyomi
    Tanaka, Hideharu
    Fukami, Kei
    Okuda, Seiya
    LIFE SCIENCES, 2009, 84 (23-24) : 853 - 856
  • [19] Effect of mild to moderate chronic kidney disease on progression of calcilic aortic stenosis
    Ng, Charlotte
    Kamalesh, Masoor
    El Masry, Hicham
    Eckert, George
    Sawada, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 308A - 308A
  • [20] Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction
    Bellasi, Antonio
    Mandreoli, Marcora
    Baldrati, Leopoldo
    Corradini, Matteo
    Di Nicolo, Pierpaolo
    Malmusi, Giulio
    Santoro, Antonio
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04): : 883 - 891
12345